ECM News in brief, February 4, 2011

04 Feb 2011


Philogen launches in Milan

Swiss-Italian biotech company Philogen launched a Eu58.05m IPO on Thursday via Banca IMI and UBS.

The deal will sell a maximum of 10.7 million shares, of which 8.9 million are new and 1.8 million are existing shares. If all the shares are sold, the IPO ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial